地塞米松联合盐酸奥洛他定治疗过敏性结膜炎的临床效果  

Dexamethasone Combined With the Clinical Effect of Olopatadine Hydrochloride for the Treatment of Allergic Conjunctivitis

作　　者：杨海婷[1] 

机构地区：[1]黑龙江省电力医院眼科,黑龙江哈尔滨150030

出　　处：《中国继续医学教育》2017年第24期165-166,共2页China Continuing Medical Education

摘　　要：目的研究分析过敏性结膜炎使用氯雷他定或氯雷他定结合地塞米松联合盐酸奥洛他定治疗的临床效果。方法根据2013年2月—2015年2月我院的140例过敏性结膜炎患者来分析研究,将患者分成常规组和试验组,均有70例。常规组患者接受氯雷他定治疗,试验组接受氯雷他定和地塞米松联合盐酸奥洛他定进行治疗,对两组的临床治疗效果进行对比。结果常规组共有15例治愈,18例显效,16例有效,21例无效,临床治疗有效率是70.00%(49/70);试验组有30例治愈,20例显效,17例有效,3例无效,临床治疗有效率是95.7%(67/70)高于常规组,差异有统计学意义(P<0.05)。结论氯雷他定、地塞米松、盐酸奥洛他定联合治疗过敏性结膜炎的效果比常规氯雷他定治疗优秀。Objective Study on the clinical efect of allergic conjunctivitis or loratadine combined with dexamethasone combined with loratadine use in olopatadine hydrochloride treatment. Methods From February 2013 to February 2015, 140 cases of allergic conjunctivitis patients to analyze and study, they were divided into conventional group and experimental group, 70 cases in each group. The conventional group received loratadine treatment, the experimental group received loratadine and dexamethasone combined with olopatadine hydrochloride treatment, compared the clinical therapeutic effect of two groups. Results In the conventional group, 15 cases were cured, 18 cases were markedly effective, 16 cases were efective, 21 cases were inefective, and the efective rate was 70% （49/70）; In the experimental group, 30 cases were cured, 20 cases were markedly efective, 17 cases were efective, 3 cases were inefective, and the efective rate of clinical treatment was 95.7% （67/70）. The effective rate of the treatment group than the conventional group, the diference was statistically signifcant （P 〈 0.05）. Conclusion The efect of loratadine, dexamethasone, olopatadine hydrochloride combined treatment of allergic conjunctivitis than conventional loratadine in the treatment of outstanding.

关 键 词：地塞米松 盐酸奥洛他定 氯雷他定 过敏性结膜炎 病例对照研究 

分 类 号：R777[医药卫生—眼科]